Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells
Open Access
- 30 August 2017
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 15 (1) , 1-10
Abstract
Lung cancer stem cells (CSCs) are considered to be the seed of lung cancer, and CD133 is a marker of lung CSCs. Here, we developed gefitinib-loaded poly(ethylene glycol) 2000-distearoylphosphatidylethanolamine nanomicelles with CD133 aptamers (M-Gef-CD133) to eliminate CD133+ lung CSCs. M-Gef-CD133 was prepared using a lipid-film-based approach. The targeting and activity of M-Gef-CD133 towards lung CSCs were evaluated. M-Gef-CD133 were small (25 nm) and showed enhanced cytotoxic effect towards CD133+ lung CSCs compared with non-targeted M-Gef and gefitinib. Notably, M-Gef-CD133 could significantly reduce tumor sphere formation and the percentage of CD133+ lung CSCs, indicating that it possesses selective toxicity against CD133+ lung CSCs. The interaction of CD133 aptamers and CD133 shows promise in the delivery of gefitinib to CD133+ lung CSCs, and M-Gef-CD133 represents a promising treatment to target lung CSCs.Keywords
Funding Information
- National Natural Science Foundation of China (CN) (81300008)
- Hubei Provincial Natural Science Fund (2013CFB372)
This publication has 42 references indexed in Scilit:
- Nanomedicine Strategies for sustained, Controlled and Targeted Treatment of Cancer Stem CellsNanomedicine, 2016
- Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive systemWorld Journal of Gastrointestinal Oncology, 2016
- iRGD-Conjugated DSPE-PEG2000 Nanomicelles for Targeted Delivery of Salinomycin for Treatment of Both Liver Cancer Cells Cancer Stem CellsNanomedicine, 2015
- Nanomedicine for Treatment of Cancer Stem CellsNanomedicine, 2014
- Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem CellsCell Stem Cell, 2011
- Pulsed Ultrasound Enhances Nanoparticle Penetration into Breast Cancer SpheroidsMolecular Pharmaceutics, 2010
- Antibody Engineering Promotes Nanomedicine for Cancer TreatmentNanomedicine, 2010
- The antiangiogenic efficacy of NGR-modified PEG–DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in ratsJournal of Drug Targeting, 2010
- Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem CellsCancer Research, 2006
- In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: Effects of PEG chain length and PC incorporationJournal of Pharmaceutical Sciences, 2004